The inverse correlation between combined HSP90/CHIP expression and ARF is more substantial in advanced NSCLC than in the early stage, suggesting that combined HSP90/CHIP expression may be an independent prognostic marker for early detection of NSCLC. Here, CDKN2A is linked to non-small cell lung carcinoma.